Related Experiment Video
Updated: Aug 20, 2026

Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions
Published on: October 21, 2017
Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white
Angus M Brown1, Helle M Sickmann, Keld Fosgerau
1Department of Neurology, University of Washington, Seattle, WA, USA. ambrown@nottingham.ac.uk
Abstract:
We tested the hypothesis that inhibiting glycogen degradation accelerates compound action potential (CAP) failure in mouse optic nerve (MON) during aglycemia or high-intensity stimulation. Axon function was assessed as the evoked CAP, and glycogen content was measured biochemically. Isofagomine, a novel inhibitor of central nervous system (CNS) glycogen phosphorylase, significantly increased glycogen content under normoglycemic conditions. When MONs were bathed in artificial cerebrospinal fluid (aCSF) containing 10 mM glucose, the CAP failed 16 min after exposure to glucose-free aCSF. MONs bathed in aCSF plus isofagomine displayed accelerated CAP failure on glucose removal. Similar results were obtained in MONs bathed in 30 mM glucose, which increased baseline glycogen concentration. The ability of isofagomine to increase glycogen content thus was not translated into delayed CAP failure. This is likely due to the inability of the tissue to metabolize glycogen in the presence of isofagomine, highlighting the importance of glycogen in sustaining neural function during aglycemia. The hypothesis that glycogen breakdown supports intense neural activity was tested by blocking glycogen breakdown during periods of high-frequency stimulation. The CAP area declined more rapidly when glycogen metabolism was inhibited by isofagomine, explicitly showing an important physiological role for glycogen metabolism during neural activity.
Insights
Inhibiting glycogen breakdown accelerates neural function failure during glucose deprivation and high-intensity activity in mouse optic nerves. Glycogen is crucial for sustaining nerve function under these conditions.
Area of Science:
- Neuroscience
- Cellular Physiology
- Biochemistry
Background:
- Neural function relies on energy supply, with glycogen serving as a crucial energy reserve in the central nervous system.
- Understanding glycogen's role in maintaining axon function during metabolic stress is vital for neurological health.
Purpose of the Study:
- To investigate if inhibiting glycogen degradation accelerates compound action potential (CAP) failure in the mouse optic nerve (MON) during aglycemia or high-intensity stimulation.
- To elucidate the physiological role of glycogen metabolism in sustaining neural activity.
Main Methods:
- Assessed axon function via evoked CAP and measured biochemical glycogen content in mouse optic nerves.
- Utilized isofagomine, a novel inhibitor of CNS glycogen phosphorylase, to modulate glycogen metabolism.
- Exposed MONs to glucose-free artificial cerebrospinal fluid (aCSF) and high-frequency stimulation under varying glucose concentrations.
Main Results:
- Isofagomine significantly increased glycogen content under normoglycemic conditions.
- Inhibition of glycogenolysis accelerated CAP failure during aglycemia and high-frequency stimulation.
- Despite increased glycogen stores, CAP failure was not delayed when glycogen metabolism was inhibited, indicating its necessity for energy supply.
Conclusions:
- Glycogen metabolism plays a critical role in sustaining neural function during periods of aglycemia and high-intensity neural activity.
- Inhibiting glycogen breakdown impairs the optic nerve's ability to maintain function under metabolic stress.
- These findings highlight the importance of glycogen as an energy substrate for axonal function.
More Related Videos
08:36Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner
Published on: June 7, 2024
10:45Simultaneous Electroencephalography, Real-time Measurement of Lactate Concentration and Optogenetic Manipulation of Neuronal Activity in the Rodent Cerebral Cortex
Published on: December 19, 2012